Yale receives renewed lung cancer SPORE grant from NCI

NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium

Grants are flowing out of NCI again to beat the fiscal-year end deadline and some cancer researchers are starting to feel cautiously optimistic about the future.

NCI releases names of members of ad hoc working group—filling the void left by BSA

NCI has released the names of the members of the newly formed ad hoc Working Group on Extramural Research Concepts and Programs. The group will perform the peer review functions of the now-defunct Board of Scientific Advisors.

UCSF awarded $12M SPORE grant to study cancer outcomes for meningioma, prostate cancer, and breast cancer

The UCSF Helen Diller Family Comprehensive Cancer Center was awarded the Specialized Programs of Research Excellence grant by NCI for a combined program focused on cancer outcomes.

September 19, 2025

Vol.51 No.34

In Brief

UTSW receives SPORE grant from NCI to study liver cancer

The Liver Tumor Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center has been selected by NCI as a Specialized Program of Research Excellence.

September 19, 2025

Vol.51 No.34

In Brief

NCORP recognizes Kathleen Yost Butler, Kamara Mertz-Rivera, Jordan Vogelsberg with 2025 awards

The NCI Community Oncology Research Program selected Kathleen Yost Butler and Kamara Mertz-Rivera as recipients of this year’s outstanding principal investigator and administrator, respectively, at the 2025 NCORP annual meeting in Bethesda.

September 19, 2025

Vol.51 No.34

Clinical Roundup

Libtayo + chemo shows significant improvement in OS for advanced NSCLC, phase III EMPOWER-Lung 3 trial shows

Libtayo (cemiplimab) plus chemotherapy demonstrates a more than double five-year overall survival rate of 19.4%, compared to 8.8% with chemotherapy alone, according to late-breaking data from exploratory analyses at World Conference on Lung Cancer.

September 19, 2025

Vol.51 No.34

Yale receives renewed lung cancer SPORE grant from NCI

YOU MAY BE INTERESTED IN

NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium

NCI releases names of members of ad hoc working group—filling the void left by BSA

UCSF awarded $12M SPORE grant to study cancer outcomes for meningioma, prostate cancer, and breast cancer

UTSW receives SPORE grant from NCI to study liver cancer

NCORP recognizes Kathleen Yost Butler, Kamara Mertz-Rivera, Jordan Vogelsberg with 2025 awards

Libtayo + chemo shows significant improvement in OS for advanced NSCLC, phase III EMPOWER-Lung 3 trial shows

Renew today!

Subscriber content

Never miss an issue!

Login